FLGT — Fulgent Genetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Fulgent Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	450	526	424	258	336
Net Total Accounts Receivable
Net Total Receivables	143	75.1	57.4	77	91.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	612	628	508	354	550
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	71.2	98.9	95.6	112	118
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,279	1,386	1,235	1,220	1,214
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	105	88.1	73	72.9	85
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	120	119	99.2	86.7	102
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,159	1,267	1,136	1,133	1,112
Total Liabilities & Shareholders' Equity	1,279	1,386	1,235	1,220	1,214
Total Common Shares Outstanding